<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Yang Y</submitter><pubmed_abstract>Benzylisoquinoline alkaloids (BIAs) are a large family of plant natural products with important pharmaceutical applications. &lt;i>Sinomenium acutum&lt;/i> is a medicinal plant from the Menispermaceae family and has been used to treat rheumatoid arthritis for hundreds of years. &lt;i>Sinomenium acutum&lt;/i> contains more than 50 BIAs, and sinomenine is a representative BIA from this plant. Sinomenine was found to have preventive and curative effects on opioid dependence. Despite the broad applications of &lt;i>S. acutum&lt;/i>, investigation on the biosynthetic pathways of BIAs from &lt;i>S. acutum&lt;/i> is limited. In this study, we comprehensively analyzed the transcriptome data and BIAs in the root, stem, leaf, and seed of &lt;i>S. acutum&lt;/i>. Metabolic analysis showed a noticeable difference in BIA contents in</pubmed_abstract><journal>Frontiers in plant science</journal><pagination>1086335</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9808091</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Full-length transcriptome and metabolite analysis reveal reticuline epimerase-independent pathways for benzylisoquinoline alkaloids biosynthesis in &lt;i>Sinomenium acutum&lt;/i>.</pubmed_title><pmcid>PMC9808091</pmcid><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Sun R</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Xue L</pubmed_authors><pubmed_authors>Yin M</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Yan X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Full-length transcriptome and metabolite analysis reveal reticuline epimerase-independent pathways for benzylisoquinoline alkaloids biosynthesis in &lt;i>Sinomenium acutum&lt;/i>.</name><description>Benzylisoquinoline alkaloids (BIAs) are a large family of plant natural products with important pharmaceutical applications. &lt;i>Sinomenium acutum&lt;/i> is a medicinal plant from the Menispermaceae family and has been used to treat rheumatoid arthritis for hundreds of years. &lt;i>Sinomenium acutum&lt;/i> contains more than 50 BIAs, and sinomenine is a representative BIA from this plant. Sinomenine was found to have preventive and curative effects on opioid dependence. Despite the broad applications of &lt;i>S. acutum&lt;/i>, investigation on the biosynthetic pathways of BIAs from &lt;i>S. acutum&lt;/i> is limited. In this study, we comprehensively analyzed the transcriptome data and BIAs in the root, stem, leaf, and seed of &lt;i>S. acutum&lt;/i>. Metabolic analysis showed a noticeable difference in BIA contents in</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T13:52:52.778Z</modification><creation>2025-04-04T13:52:52.778Z</creation></dates><accession>S-EPMC9808091</accession><cross_references><pubmed>36605968</pubmed><doi>10.3389/fpls.2022.1086335</doi></cross_references></HashMap>